Zacks Investment Research on MSN
J&J's innovative medicine business in Q2: Here's what to watch
Johnson & Johnson JNJ, through its Innovative Medicine segment, commercializes multiple blockbuster therapies spanning a wide ...
Johnson & Johnson JNJ, under its Innovative Medicine segment, markets several multi-million-dollar drugs that cover a broad range of areas such as neuroscience, cardiovascular and metabolism, ...
I keep hitting the buy button on Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) because I have stopped trying to find a ...
Using its commercially available AI drug discovery platform, Pharma.AI, which works across biology, chemistry, and clinical medicine, Insilico has developed breakthroughs in multiple disease areas, ...
Johnson & Johnson JNJ, through its Innovative Medicine segment, commercializes multiple blockbuster therapies spanning a wide range of disease areas, such as neuroscience, cardiovascular and metabolic ...
Why do you believe master protocols are so important to the future of clinical research? A master protocol approach can provide inferential benefits and operational efficiency. Clinical development is ...
Johnson & Johnson Innovative Medicine¹ has announced its strengthened commitment in the City of Latina, Italy, with a projected investment of 580 million euros (US$622.6 million) over the next five ...
During the third quarter, JNJ generated $21.35 billion in revenue, topping the expected $21.04 billion as sales grew 6.8% YoY with JNJ earning a net income of $4.31 billion, flat compared to last year ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen by an independent group of researchers. The Nature Index provides absolute Count of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results